FILIP: Fat Intake, Inflammation and LIPids

Status: Recruiting
Location: See all (2) locations...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Low-grade inflammation is involved in the pathogenesis of type 2 diabetes and cardiovascular disease. Increasing evidence suggests that dietary intake may be involved in the inflammatory process. How nutritional composition of the diet affects the inflammatory response is however not well understood. The aim of this project is to study if intake of three different fat sources induce different effects on inflammation markers, blood lipids, blood glucose and the microbiota.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 60
Healthy Volunteers: t
View:

• Age 18-60

• Willing to eat the study diet

Locations
Other Locations
Sweden
University of Gothenburg
RECRUITING
Gothenburg
University of Gothenburg
NOT_YET_RECRUITING
Gothenburg
Contact Information
Primary
Linnea Bärebring, PhD
linnea.barebring@gu.se
0317863771
Time Frame
Start Date: 2025-04-08
Estimated Completion Date: 2026-12-31
Participants
Target number of participants: 25
Treatments
Experimental: Sequence 1: Rapeseed oil, butter, coconut oil
Diets rich in rapeseed oil, butter or coconut oil given in blinded, preprepared meals
Experimental: Sequence 2: Rapeseed oil, coconut oil, butter
Diets rich in rapeseed oil, butter or coconut oil given in blinded, preprepared meals
Experimental: Sequence 3: Butter, coconut oil , rapeseed oil
Diets rich in rapeseed oil, butter or coconut oil given in blinded, preprepared meals
Experimental: Sequence 4: Butter, rapeseed oil, coconut oil
Diets rich in rapeseed oil, butter or coconut oil given in blinded, preprepared meals
Experimental: Sequence 5: Coconut oil, rapeseed oil, butter
Diets rich in rapeseed oil, butter or coconut oil given in blinded, preprepared meals
Experimental: Sequence 6: Coconut oil, butter, rapeseed oil
Diets rich in rapeseed oil, butter or coconut oil given in blinded, preprepared meals
Related Therapeutic Areas
Sponsors
Collaborators: Chalmers University of Technology
Leads: Göteborg University

This content was sourced from clinicaltrials.gov